These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 662155)

  • 1. [Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
    Bagliani A; Moia R
    Minerva Med; 1978 Apr; 69(19):1287-93. PubMed ID: 662155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chorionic gonadotropin (HCG) in the therapy of chronic peripheral obliterating arteriopathy (CPOA) of the lower extremities caused by arteriosclerosis].
    Bonandrini L; Mantellini E; Colombo P; Seghezzi R; Lombardo F
    Minerva Chir; 1970 Mar; 25(5):368-83. PubMed ID: 5438397
    [No Abstract]   [Full Text] [Related]  

  • 4. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A; Borri P; Parravicini R
    Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
    Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
    Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
    [No Abstract]   [Full Text] [Related]  

  • 7. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transcutaneous determination of oxygen and carbon dioxide pressure in patients with obliterating atherosclerosis of blood vessels of the lower limbs].
    Shevtsov VI; Shchurova EN; Shchurov VA
    Vestn Khir Im I I Grek; 1999; 158(3):30-3. PubMed ID: 10481879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of obesity with chorionic gonadotropins. Relations between obesity, dyslipidemia and arthero-arteriosclerosis].
    Vallini A; Fabbri F; Candi L; Davi D
    Minerva Med; 1976 Jul; 67(33):2113-32. PubMed ID: 951038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 11. [On some aspects of therapy of chronic peripheral obliterating arteriopathies (C.P.O.A.) on arteriosclerotic nature].
    Seghezzi R; Borri P; Pedroni G
    Minerva Med; 1968 Dec; 59(99):5458-65. PubMed ID: 5718833
    [No Abstract]   [Full Text] [Related]  

  • 12. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
    Arrigo F; Coglitore S; Giannetto M; Bramanti O; Barbera C; Consolo F
    Boll Soc Ital Cardiol; 1977; 22(3):273-82. PubMed ID: 617274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Piribedil (TF 871) in the treatment of arteriopathies of the lower extremities].
    Argenteri A; Moia R; Negri L
    Ann Ital Chir; 1979; 51(2):145-55. PubMed ID: 554489
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the local peripheral blood flow in senile arteriosclerotic or diabetic arteriopathies].
    Dughera L; Nosenzo C; Judica-Cordiglia A; Macchioni P; Coscia GC
    Minerva Cardioangiol; 1968 Jul; 16(7):570-8. PubMed ID: 5745054
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
    Roztocil K; Oliva J; Linhart J; Prerovský I; Modr Z
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study].
    Cospite M; Ferrara F; Milio G; Meli F
    Clin Ter; 1984 Apr; 109(2):127-35. PubMed ID: 6234122
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of pathogenetic treatment of arterial obliterative diseases of the extremities].
    Belokurov IuN; Rudnev NE
    Khirurgiia (Mosk); 1993 Feb; (2):15-8. PubMed ID: 8084143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior and significance of beta-thromboglobulin in chronic obliterating arteriopathy of the lower limbs. Preliminary research].
    Binaghi F; Valle E; Manconi E; Pitzus F
    Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6085827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of chorionic gonadotropin on some serum lipid indices in atherosclerotic subjects].
    Pompei A; Belloni L; Traverso E
    Arch Maragliano Patol Clin; 1968; 24(6):729-41. PubMed ID: 5757341
    [No Abstract]   [Full Text] [Related]  

  • 20. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
    Toth L
    Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.